Sofwave: how it works, results and how long they last

Sofwave is a noninvasive lifting procedure that distributes ultrasound energy evenly across the mid-dermis in broad parallel beams rather than concentrating it at one point.

Conventional ultrasound lifting focuses energy at points to reach deeper layers, but Sofwave uses a different method.

Multiple transducers emit parallel ultrasound simultaneously, delivering broad, even thermal stimulation throughout the mid-dermis at approximately 1.5mm.

This thermal stimulation partially denatures dermal collagen, which is understood to trigger the formation of new collagen and elastin.

Animal experiments observed dermal temperatures of 60–70°C immediately after treatment while surface temperatures stayed below 40°C, illustrating a design that selectively stimulates the dermis while protecting the epidermis.

Human biopsies also showed increased mid-dermal collagen-fiber density and longer, straighter rearrangement of elastic fibers 2 months after treatment.

Both use ultrasound for lifting, but energy delivery and target layers differ.

Focused ultrasound such as Ultherapy concentrates energy at points as deep as the SMAS (fascial layer), with depths including 1.5mm, 3.0mm and 4.5mm.

Sofwave instead spreads nonfocused parallel beams broadly at a single mid-dermal depth.

It is more accurate to see them as tools for different layers rather than rank one above the other.

A comparative study of inner-arm laxity reported similar efficacy and no major pain difference between parallel and focused beams, with a shorter treatment time for parallel beams.

It may be especially helpful for mild to moderate laxity in people seeking gradual tightening and texture improvement without surgery.

Some research reports relatively better responses in early stages when nasolabial or marionette-line depressions are not yet deep.

With advanced sagging or substantial drooping of subcutaneous fat, ultrasound lifting generally may have limited effects, so combination with treatments targeting other layers is considered.

Because this energy is not affected by melanin, applicability is relatively broad even for darker skin tones.

One study found significant reductions in nasolabial and marionette-line depressions from around 1 month; over 60% of participants reported improvement then.

Further changes between months 1 and 3 were small, suggesting much of the change occurred early.

A pilot acne-scar study reported roughly 23–27% less depressed volume after just 1 session, with a mean 3.6-month follow-up.

However, studies to date are small and short-term, so evidence for long-term durability remains insufficient.

The degree and duration of firmness vary considerably with individual characteristics and care.

I recommend Sofwave to people who are not ready for surgical lifting but want natural improvements in texture and fine lines.

Downtime is relatively short and change may follow a single session, making it an option for those wanting minimal disruption to daily life.

With advanced sagging, Sofwave alone may not provide satisfying change, so I openly discuss combinations or alternatives.

As an emerging technology, it still lacks large, long-term studies; I explain this in advance and prioritize suitability over sales.

We assess laxity, skin thickness and expectations together to decide the plan (individual results vary).